OTCMKTS:AFFY - Affymax Stock Price, News, & Analysis

Get Started

$0.0240 0.00 (0.00 %)

(As of 03/19/2019 04:00 PM ET)

Previous Close$0.0250

Today's Range$0.0240 - $0.0240

52-Week Range$0.0110 - $0.05

Volume1,000 shs

Average Volume24,785 shs

Market Capitalization$899,760.00

P/E RatioN/A

Dividend YieldN/A

Beta4.07

Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York.

Receive AFFY News and Ratings via Email

Sign-up to receive the latest news and ratings for AFFY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Pharmaceutical preparations

Sub-IndustryBiotechnology

SectorMedical

Current SymbolOTCMKTS:AFFY

Previous Symbol

CUSIP00826A10

CIK1158223

Webwww.affymax.com

Phone650-812-8700

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

EmployeesN/A

Outstanding Shares37,490,000

Market Cap$899,760.00

Next Earnings DateN/A

OptionableNot Optionable

Affymax (OTCMKTS:AFFY) Frequently Asked Questions

What is Affymax's stock symbol?

Affymax trades on the OTCMKTS under the ticker symbol "AFFY."

Has Affymax been receiving favorable news coverage?

Media headlines about AFFY stock have trended neutral this week, according to InfoTrie. InfoTrie ranks the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Affymax earned a coverage optimism score of 0.4 on InfoTrie's scale. They also assigned news headlines about the biopharmaceutical company a news buzz of 6.0 out of 10, indicating that recent news coverage is somewhat likely to have an effect on the stock's share price in the near term.

Who are some of Affymax's key competitors?

Some companies that are related to Affymax include Propanc Biopharma (PPCB), Boston Therapeutics (BTHE), Respirerx Pharmaceuticals (RSPI), Integrated BioPharma (INBP), Synergy Pharmaceuticals (SGYP), Anthera Pharmaceuticals (ANTH), Immune Therapeutics (IMUN), American Bio Medica (ABMC), Global Future City (FTCY), Mabvax Therapeutics (MBVX), Cotinga Pharmaceuticals (COTQF), RXi Pharmaceuticals (RXII), Capstone Therapeutics (CAPS), Pernix Therapeutics (PTX) and Aoxing Pharmaceutical (AOXG).

What other stocks do shareholders of Affymax own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Affymax investors own include Phillips 66 (PSX), CASI Pharmaceuticals (CASI), Pulse Biosciences (PLSE), Mesoblast (MESO), Editas Medicine (EDIT), Fate Therapeutics (FATE), Aurinia Pharmaceuticals (AUPH), Molycorp (MCPIQ), Gilead Sciences (GILD) and SUMMIT THERAPEU/S (SMMT).

Who are Affymax's key executives?

Affymax's management team includes the folowing people:

Mr. Mark G. Thompson, CFO & Sec. (Age 57)
Mr. Jonathan M. Couchman, CEO, Pres & Director (Age 49)
Dr. Tracy J. Dunn Ph.D., J.D., VP of Intellectual Property & Legal Affairs (Age 56)

How do I buy shares of Affymax?

Shares of AFFY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Affymax's stock price today?

One share of AFFY stock can currently be purchased for approximately $0.0240.

How big of a company is Affymax?

Affymax has a market capitalization of $899,760.00.

What is Affymax's official website?

The official website for Affymax is http://www.affymax.com.

How can I contact Affymax?

Affymax's mailing address is 19200 STEVENS CREEK BOULEVARD SUITE 240, CUPERTINO CA, 95014. The biopharmaceutical company can be reached via phone at 650-812-8700 or via email at [email protected]

MarketBeat Community Rating for Affymax (OTCMKTS AFFY)

Community Ranking:		3.0 out of 5 ( )
Outperform Votes:		171 (Vote Outperform)
Underperform Votes:		113 (Vote Underperform)
Total Votes:		284

MarketBeat's community ratings are surveys of what our community members think about Affymax and other stocks. Vote "Outperform" if you believe AFFY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AFFY will underperform the S&P 500 over the long term. You may vote once every thirty days.

This page was last updated on 3/19/2019 by MarketBeat.com Staff